A biotech company accelerating the clinical
development of innovative vaccine products
Established inNovember 2017.
Address1616 Eastlake Avenue East Suite 290,
Seattle WA 98102
ContactTel. +1-206-492-5722
Curevo is a Seattle-based biotech company that is currently
conducting clinical trials on the next-generation vaccine
against varicella zoster (CRV101).
The company is transforming itself into a future leader of the
global vaccine market, conducting clinical trials on a wide
range of innovative vaccines against a variety of infectious and
contagious diseases.
Through partnership with the world-class Infectious Disease
Research Institute (IDRI), Curevo continues to augment its
expertise.